Clinical Trials Browser

Phase NA × Bevacizumab × Thoracic × Clear all

NCT07398599 2026-02-10

Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Meningeal Carcinomatosis

NCT06643000 2025-03-06

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT04973293 2024-11-19

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

Phase NA Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05407155 2022-06-07

BETTER

Phase NA Unknown

Non-small Cell Lung Cancer Metastatic

NCT04944069 2021-06-29

ATTRACT

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT01063283 2019-11-18

AVF4759

Phase NA Completed

20 enrolled 9 charts

Advanced Non-squamous Non-Small Cell Lung Cancer

NCT00675597 2015-11-20

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

Phase NA Completed

25 enrolled 6 charts

Lung Neoplasms

NCT02195336 2014-07-21

BevMar

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung